Table 3.
Percentages of incident hemodialysis and peritoneal dialysis patients with prescriptions for specific blood pressure medications at 6 months by cardiovascular risk factor or disease, 2003-2008
| |
Hemodialysis,
n = 12,159 |
Peritoneal dialysis,
n = 913 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
CHF |
CVD |
Diabetes |
|
CHF |
CVD |
Diabetes |
||||||
| Medication | All | Yes | No | Yes | No | Yes | No | All | Yes | No | Yes | No | Yes | No |
| None |
12 |
10 |
13 |
11 |
13 |
10 |
15 |
10 |
7 |
10 |
7 |
11 |
5 |
14 |
|
Beta-blocker |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Any |
59 |
65 |
55 |
64 |
53 |
62 |
54 |
55 |
69 |
51 |
67 |
48 |
61 |
48 |
| Alpha-beta |
19 |
26 |
13 |
22 |
15 |
20 |
16 |
13 |
25 |
10 |
17 |
11 |
16 |
10 |
| Beta not alpha |
41 |
39 |
42 |
43 |
38 |
42 |
38 |
42 |
44 |
41 |
51 |
37 |
45 |
38 |
|
RAS
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Any |
45 |
45 |
45 |
44 |
46 |
49 |
39 |
52 |
54 |
51 |
55 |
50 |
57 |
46 |
| ACEI |
32 |
32 |
31 |
31 |
32 |
34 |
27 |
33 |
36 |
32 |
34 |
32 |
35 |
30 |
| ARB |
17 |
16 |
17 |
16 |
18 |
19 |
14 |
23 |
22 |
23 |
25 |
22 |
26 |
19 |
|
CCB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Any |
49 |
44 |
52 |
45 |
52 |
49 |
47 |
50 |
43 |
51 |
48 |
51 |
54 |
44 |
| DHP |
40 |
36 |
43 |
37 |
43 |
41 |
39 |
40 |
35 |
41 |
38 |
41 |
42 |
37 |
| Non-DHP |
9 |
8 |
9 |
8 |
9 |
9 |
8 |
10 |
8 |
10 |
10 |
10 |
13 |
7 |
|
Diuretic
†
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Any |
28 |
31 |
24 |
28 |
26 |
31 |
21 |
41 |
55 |
37 |
52 |
35 |
50 |
32 |
| Loop |
26 |
30 |
22 |
26 |
24 |
29 |
19 |
38 |
53 |
34 |
50 |
33 |
47 |
29 |
| Thiazide |
5 |
5 |
4 |
4 |
5 |
5 |
3 |
9 |
13 |
8 |
13 |
6 |
12 |
5 |
| Alpha blocker |
7 |
6 |
7 |
7 |
6 |
7 |
7 |
10 |
8 |
10 |
12 |
9 |
11 |
7 |
| Central alpha 2 agonist |
19 |
18 |
20 |
17 |
21 |
20 |
18 |
15 |
14 |
16 |
14 |
16 |
16 |
14 |
| Hydralazine |
8 |
11 |
6 |
9 |
7 |
9 |
7 |
4 |
9 |
3 |
5 |
4 |
6 |
3 |
| Minoxidil | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 2 | 2 | 3 | 1 | 3 | 2 | 2 |
Note: Values are percentages except for the n row, which represents number of individuals.
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DHP, dihydropyridine; RAS, renin angiotensin system agent.
*Renin-inhibitors comprised < 1% of RAS agents from 2003–2008.
†Potassium-sparing diuretics comprised < 1% of diuretic agents from 2003–2008.